Banner Publications MH200828 N141

Publications

Results found: 7954

Showing results: 451 - 500

Journal of cancer survivorship : research and practice

Socioeconomic differences in health-related quality of life among cancer survivors and comparison with a cancer-free population: a PROFILES study.

29-11-2023
Cancers

Identifying Genetic Mutation Status in Patients with Colorectal Cancer Liver Metastases Using Radiomics-Based Machine-Learning Models.

29-11-2023
Nederlands tijdschrift voor geneeskunde

[Childhood cancer after fertility treatments?].

28-11-2023
Blood advances

International validation of a health-related quality-of-life questionnaire for Hodgkin lymphoma: the EORTC QLQ-HL27.

28-11-2023
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

A qualitative study on the healthcare experiences of adolescents and young adults (AYA) with an uncertain or poor cancer prognosis.

27-11-2023
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Health-related quality of life after stereotactic radiosurgery in patients with brain metastases.

27-11-2023
Journal of medical genetics

Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel.

27-11-2023
Insights into imaging

Results of a diagnostic imaging audit in a randomised clinical trial in rectal cancer highlight the importance of careful planning and quality control.

24-11-2023
Cancers

Time Trends in the Treatment and Survival of 5036 Uveal Melanoma Patients in The Netherlands over a 30-Year Period.

15-11-2023
Health and quality of life outcomes

Development and psychometric evaluation of item banks for memory and attention - supplements to the EORTC CAT Core instrument.

15-11-2023
Research square

The prognostic value of tumor-stroma ratio and a newly developed computer-aided quantitative analysis of routine H&E slides in high-grade serous ovarian cancer.

14-11-2023
BMC cancer

Personalized surveillance and aftercare for non-metastasized breast cancer: the NABOR study protocol of a multiple interrupted time series design.

14-11-2023
Supportive Care in Cancer

Perspectives of patients with metastatic breast cancer on physical exercise programs: results from a survey in five European countries

13-11-2023
Key
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Perspectives of patients with metastatic breast cancer on physical exercise programs: results from a survey in five European countries.

13-11-2023
Cancer research communications

Risk Prediction of Metachronous Colorectal Cancer from Molecular Features of Adenomas: A Nested Case-Control Study.

13-11-2023
BJR open

How to 19F MRI: applications, technique, and getting started.

13-11-2023
Breast cancer research : BCR

PROACTING: predicting pathological complete response to neoadjuvant chemotherapy in breast cancer from routine diagnostic histopathology biopsies with deep learning.

13-11-2023
Science (New York, N.Y.)

How do molecular motors fold the genome?

10-11-2023
Nucleic acids research

Compartmentalization of androgen receptors at endogenous genes in living cells.

10-11-2023
Journal of visualized experiments : JoVE

Gut Isolation from Zebrafish Larvae for Single-cell RNA Sequencing.

10-11-2023
Science

How do molecular motors fold the genome?

09-11-2023
The New England journal of medicine

Severe Immune-Related Enteritis after In Utero Exposure to Pembrolizumab.

09-11-2023
The New England journal of medicine

Nivolumab plus Gemcitabine-Cisplatin in Advanced Urothelial Carcinoma.

09-11-2023
Journal of the National Cancer Institute

Contralateral breast cancer risk in patients with breast cancer and a germline-BRCA1/2 pathogenic variant undergoing radiation.

08-11-2023
Journal of the National Cancer Institute

Financial outcomes of adolescent and young adult cancer survivors: a longitudinal population-based registry study.

08-11-2023
Expert review of molecular diagnostics

Cross-sectional risk models using quantitative fecal hemoglobin in colorectal cancer screening: a systematic review.

06-11-2023
The Journal of antimicrobial chemotherapy

Population pharmacokinetics of a combination of miltefosine and paromomycin in Eastern African children and adults with visceral leishmaniasis.

06-11-2023
The Journal of experimental medicine

MYC is a clinically significant driver of mTOR inhibitor resistance in breast cancer.

06-11-2023
Cancer medicine

Therapeutic drug monitoring to personalize dosing of imatinib, sunitinib, and pazopanib: A mixed methods study on barriers and facilitators.

01-11-2023
Cancer discovery

Biomarker-Driven Personalization of Neoadjuvant Immunotherapy in Melanoma.

01-11-2023
Nature genetics

Author Correction: Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk.

01-11-2023
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

EORTC 1409 GITCG/ESSO 01 - A prospective colorectal liver metastasis database for borderline or initially unresectable diseases (CLIMB): Lessons learnt from real life. From paradigm to unmet need.

01-11-2023
European urology

Grade Group 1 Prostate Cancers Exhibit Tumor-defining Androgen Receptor-driven Programs.

01-11-2023
European journal of cancer (Oxford, England : 1990)

Diagnostic accuracy of CT for local staging of colon cancer: A nationwide study in the Netherlands.

01-11-2023
Nature medicine

CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211-01 trial.

01-11-2023
The British journal of radiology

Sense and non-sense of imaging in the era of organ preservation for rectal cancer.

01-11-2023
Journal of cancer research and clinical oncology

Clinical and self-reported markers of reproductive function in female survivors of childhood Hodgkin lymphoma.

01-11-2023
Paediatric drugs

Azacitidine (Vidaza®) in Pediatric Patients with Relapsed Advanced MDS and JMML: Results of a Phase I/II Study by the ITCC Consortium and the EWOG-MDS Group (Study ITCC-015).

01-11-2023
The Lancet. Oncology

Pembrolizumab plus lenvatinib in second-line and third-line patients with pleural mesothelioma (PEMMELA): a single-arm phase 2 study.

01-11-2023
Life science alliance

Grp78 is required for intestinal Kras-dependent glycolysis proliferation and adenomagenesis.

01-11-2023
Urologic oncology

Patient-reported outcome measures compared to clinician reported outcomes regarding incontinence and erectile dysfunction in localized prostate carcinoma after robot assisted radical prostatectomy: Impact on management.

01-11-2023
The Journal of biological chemistry

STPP-UP: An alternative method for drug target identification using protein thermal stability.

01-11-2023
Biomedical chromatography : BMC

Development and validation of an HPLC-MS/MS method to quantify the KRAS inhibitor adagrasib in mouse plasma and tissue-related matrices.

01-11-2023
Journal for immunotherapy of cancer

Quantifying the impact of immunotherapy on RNA dynamics in cancer.

01-11-2023
Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Atezolizumab With or Without Radiotherapy for Advanced Squamous Cell Carcinoma of the Penis (The PERICLES Study): A Phase II Trial.

01-11-2023
Clinical and translational radiation oncology

Adaptive FDG-PET/CT guided dose escalation in head and neck squamous cell carcinoma: Late toxicity and oncologic outcomes (The ADMIRE study).

01-11-2023
Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Reply to G. Wang et al.

01-11-2023
European journal of cancer (Oxford, England : 1990)

Pharmacokinetic boosting of olaparib: A randomised, cross-over study (PROACTIVE-study).

01-11-2023
Cancer discovery

Transposable Elements Are Co-opted as Oncogenic Regulatory Elements by Lineage-Specific Transcription Factors in Prostate Cancer.

01-11-2023
Cancer immunology, immunotherapy : CII

Immune checkpoint inhibitor-induced neurotoxicity is not associated with seroprevalence of neurotropic infections.

01-11-2023

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.